- Title
- The Fast Cognitive Evaluation (FaCE) : a screening tool to detect cognitive impairment in patients with cancer
- Creator
- Baghdadli, Amel; Arcuri, Giovanni; Green, Clarence; Gauthier, Lynn; Gagnon, Pierre; Gagnon, Bruno
- Date
- 2023
- Type
- Text; Journal article
- Identifier
- http://researchonline.federation.edu.au/vital/access/HandleResolver/1959.17/197904
- Identifier
- vital:18934
- Identifier
-
https://doi.org/10.1186/s12885-022-10470-1
- Identifier
- ISSN:1471-2407 (ISSN)
- Abstract
- Cancer-related cognitive impairment (CRCI) is one of the most concerning conditions experienced by patients living with cancer and has a major impact on their quality of life. Available cognitive assessment tools are too time consuming for day-to-day clinical setting assessments. Importantly, although shorter, screening tools such as the Montreal Cognitive Assessment or the Mini-Mental State Evaluation have demonstrated a ceiling effect in persons with cancer, and thus fail to detect subtle cognitive changes expected in patients with CRCI. This study addresses this lack of cognitive screening tools by developing a novel tool, the Fast Cognitive Evaluation (FaCE). A population of 245 patients with 11 types of cancer at different illness and treatment time-points was enrolled for the analysis. FaCE was developed using Rasch Measurement Theory, a model that establishes the conditions for a measurement tool to be considered a rating scale. FaCE shows excellent psychometric properties. The population size was large enough to test the set of items (item-reliability-index=0.96). Person-reliability (0.65) and person-separation (1.37) indexes indicate excellent internal consistency. FaCE’s scale is accurate (reliable) with high discriminant ability between cognitive levels. Within the average testing time of five minutes, FaCE assesses the main cognitive domains affected in CRCI. FaCE is a rapid, reliable, and sensitive tool for detecting even minimal cognitive changes over time. This can contribute to early and appropriate interventions for better quality of life in patients with CRCI. In addition, FaCE could be used as a measurement tool in research exploring cognitive disorders in cancer survivors. © 2023, The Author(s).
- Publisher
- BioMed Central Ltd
- Relation
- BMC Cancer Vol. 23, no. 1 (2023), p.
- Rights
- All metadata describing materials held in, or linked to, the repository is freely available under a CC0 licence
- Rights
- http://creativecommons.org/licenses/by/4.0/
- Rights
- Copyright © 2023, The Author(s)
- Rights
- Open Access
- Subject
- 3211 Oncology and carcinogenesis; 4202 Epidemiology; Brain fog; Cancer; Chemo brain; Cognition; Memory; Mild cognitive impairment
- Full Text
- Reviewed
- Funder
- This study was supported in part from a student grant from the Centre de Recherche du CHU de Québec-Université Laval awarded to Dr. Bruno Gagnon. A portion of the data from women with breast cancer were drawn from a study supported by funds awarded to Dr. Lynn R. Gauthier from the Canadian Pain Society/Pfizer Early Career Investigator Pain Research Grant, the Fonds de recherche du Quebec – Santé, and the Fondation J.-Louis Lévesque.
- Hits: 475
- Visitors: 477
- Downloads: 5
| Thumbnail | File | Description | Size | Format | |||
|---|---|---|---|---|---|---|---|
| View Details Download | SOURCE1 | Published version | 1 MB | Adobe Acrobat PDF | View Details Download |